Stay updated on Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial
Sign up to get notified when there's something new on the Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial page.

Latest updates to the Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe page now shows Revision: v3.5.4 instead of Revision: v3.5.3, signaling a minor version update to the site’s UI. This change does not affect study data, navigation, or user interactions.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedTwo new history entries (IDs 1048 and 1049) were added with updates to the Study Status and Contacts/Locations sections, and an older version (dated 2025-11-25) was deleted.SummaryDifference0.0%

- Check32 days agoChange DetectedThe page’s displayed system revision identifier is updated from v3.5.2 to v3.5.3, reflecting a site/version maintenance change rather than an update to the clinical trial record.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision: v3.5.2 was added to the history; Revision: v3.5.0 was removed.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision v3.5.0 was added to the history, and Revision v3.4.3 was removed.SummaryDifference0.0%

- Check78 days agoChange Detected- The page now displays Revision: v3.4.3 and no longer displays Revision: v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial page.